GenFleet Therapeutics (Shanghai) Inc

NEW
HAM:Y3L (China)   Ordinary Shares-Class H
€ 2.916 -0.084 (-2.8%) Aug 3
At Loss
P/B:
5.12
Market Cap:
€ 1.18B ($ 1.36B)
Enterprise V:
€ 924.96M ($ 1.06B)
Volume:
0
Avg Vol (2M):
750.00
Trade In:

Business Description

Description
GenFleet Therapeutics (Shanghai) Inc Company is a clinical-stage biotechnology company. The Company and its subsidiaries are principally engaged in the research, development and commercialisation of pharmaceutical products. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment.
Name Current Vs Industry Vs History
Cash-To-Debt
20.56
Equity-to-Asset
0.83
Debt-to-Equity
0.06
Debt-to-EBITDA
-0.06
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
11.56
Distress
Grey
Safe
Beneish M-Score
-6.39
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y Total Revenue Growth Rate Estimate
56.78

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
20.85
9-Day RSI
29.76
14-Day RSI
35.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
5.85
Quick Ratio
5.8
Cash Ratio
5.61
Days Inventory
61.97
Days Sales Outstanding
204.41
Days Payable
152.85

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield %
-19.2
Name Current Vs Industry Vs History
Gross Margin %
64.1
Operating Margin %
-213.13
Net Margin %
-1381.85
EBITDA Margin %
-1369.32
FCF Margin %
-104.39
OCF Margin %
-104.31
ROA %
-161.09
ROIC %
-14.66
ROC (Joel Greenblatt) %
-7499.88
ROCE %
-128512.3

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio
68.49
PB Ratio
5.12
Price-to-Tangible-Book
4.94
EV-to-EBIT
-4.25
EV-to-EBITDA
-4.27
EV-to-Revenue
58.54
EV-to-FCF
-55.96
Price-to-Net-Current-Asset-Value 5.12
Price-to-Net-Cash 5.3
Earnings Yield (Greenblatt) %
-23.53
FCF Yield %
-1.4

Financials

HAM:Y3L's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

GenFleet Therapeutics (Shanghai) Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 15.75
EPS (TTM) (€) -0.603
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI 35.77
14-Day ATR (€) 0.201706
20-Day SMA (€) 3.755
12-1 Month Momentum % -
52-Week Range (€) 2.672 - 4.612
Shares Outstanding (Mil) 383.97

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

GenFleet Therapeutics (Shanghai) Inc Filings

Filing Date Document Date Form
No Filing Data

GenFleet Therapeutics (Shanghai) Inc Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

GenFleet Therapeutics (Shanghai) Inc Frequently Asked Questions

What is GenFleet Therapeutics (Shanghai) Inc(HAM:Y3L)'s stock price today?
The current price of HAM:Y3L is €2.92. The 52 week high of HAM:Y3L is €4.61 and 52 week low is €2.67.
When is next earnings date of GenFleet Therapeutics (Shanghai) Inc(HAM:Y3L)?
The next earnings date of GenFleet Therapeutics (Shanghai) Inc(HAM:Y3L) is .
Does GenFleet Therapeutics (Shanghai) Inc(HAM:Y3L) pay dividends? If so, how much?
GenFleet Therapeutics (Shanghai) Inc(HAM:Y3L) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on GenFleet Therapeutics (Shanghai) Inc

No articles.